PRESS RELEASE published on 10/20/2023 at 15:40, 2 years 11 months ago Eckert & Ziegler and Supervisory Board Decide on Investment Priorities for 2024: Focus on Core Competencies and Split-Off of Pentixapharm AG
PRESS RELEASE published on 10/20/2023 at 15:18, 2 years 11 months ago EQS-Adhoc: Eckert & Ziegler Focuses on Core Competence and Prepares Split-Off of Clinical Assets
PRESS RELEASE published on 10/17/2023 at 16:57, 2 years 11 months ago EQS-Adhoc: Eckert & Ziegler Achieves Double-Digit Growth in Q3 versus Previous Year. Significant Jump in Sales also in First 9 Months, Earnings still Burdened by Special Items Compared to Same Period Last Year.
PRESS RELEASE published on 10/10/2023 at 15:00, 2 years 11 months ago Eckert & Ziegler and PharmaLogic Sign Reservation Agreement for Supply of Therapeutic Radioisotope Actinium-225
PRESS RELEASE published on 09/28/2023 at 10:00, 3 years ago Eckert & Ziegler Receives Award for Professional Training
PRESS RELEASE published on 09/25/2023 at 23:17, 3 years ago EQS-Adhoc: Eckert & Ziegler Signs Strategically Important Agreement for the Supply of Lutetium-177 with POINT Biopharma
PRESS RELEASE published on 09/13/2023 at 15:00, 3 years ago Eckert & Ziegler collaborates with RefleXion Medical and Telix Pharmaceuticals to Expand Treatment Options for Prostate Cancer Patients
PRESS RELEASE published on 08/10/2023 at 07:45, 3 years 1 month ago Eckert & Ziegler Continues Positive Sales Development in the First Half of 2023
PRESS RELEASE published on 07/21/2023 at 15:21, 3 years 2 months ago EQS-Adhoc: Eckert & Ziegler again achieves sales growth compared to the previous year and confirms its forecast for 2023. Decline in earnings compared to same period last year due to extraordinary items.
PRESS RELEASE published on 06/08/2023 at 11:31, 3 years 3 months ago Eckert & Ziegler: PentixaPharm Receives BfArM-Clearance for its Therapeutic to conduct a Clinical Trial in Lymphoma
Published on 10/02/2026 at 00:30, 2 hours 11 minutes ago Immutable Holdings Provides Corporate Update
Published on 10/01/2026 at 23:05, 3 hours 36 minutes ago Vox Royalty Expands Revolving Credit Facility Up to $150 Million and Strengthens Leadership Team
Published on 10/01/2026 at 22:00, 4 hours 41 minutes ago Golden Minerals Company Announces New Management Appointments and Resignation of Mr. Pablo Castanos
Published on 10/01/2026 at 19:05, 7 hours 36 minutes ago PEL 90 Participating Interest Exchange with Chevron
Published on 10/02/2026 at 00:01, 2 hours 40 minutes ago PolyPeptide publishes the invitation to its extraordinary general meeting of shareholders on 26 October 2026
Published on 10/01/2026 at 23:15, 3 hours 25 minutes ago CaseBioscience® Joins Team Awarded Up to $7.3 Million by ARPA-H to Advance Ambient Preservation of Cell Therapies
Published on 10/01/2026 at 20:45, 5 hours 55 minutes ago Ditto Named a Product Leader in KuppingerCole Analysts Leadership Compass for Identity Verification
Published on 10/01/2026 at 20:30, 6 hours 11 minutes ago Eleving Group prices EUR 200 million senior secured bonds at 9% in private placement – EUR 25 million exchange offer to follow
Published on 10/01/2026 at 18:55, 7 hours 45 minutes ago Ondo Finance Announces Expansion of Ondo Intelligent Portfolios to Seven With New Magnificent 7, AI and Targeted Portfolios
Published on 10/01/2026 at 19:00, 7 hours 41 minutes ago AMA CORP PLC reduces its cost base while preserving XpertEye’s key functions
Published on 10/01/2026 at 18:40, 8 hours ago Monthly disclosure of the total number of shares and voting rights - September 2026
Published on 10/01/2026 at 18:05, 8 hours 36 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 10/01/2026 at 18:00, 8 hours 40 minutes ago Saint-Gobain completes the acquisition of Xypex (North America), a leader in high value-added waterproofing solutions
Published on 10/01/2026 at 17:55, 8 hours 45 minutes ago Disclosure of transactions in own shares from September 28 to September 30, 2026
